DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2006 archives
Click here to return to the current data set

Search for Tradename: atacand

Summary for Tradename: atacand

Patents:5
Applicants:1
NDAs:2
2009 Sales:$152,603,000
Therapeutic Class:Cardiovascular Agents

Latest news for ATACAND

Courtesy of Yahoo News

Glossary
Applicant Tradename Generic Name NDA Approval Date Type RLD Patent Number Patent Expiration Exclusivity Expiration
AstrazenecaATACANDcandesartan cilexetil020838Jun 4, 1998RXNoFEB 22,2008
AstrazenecaATACANDcandesartan cilexetil020838Jun 4, 1998RXNoMAY 18,2008
AstrazenecaATACANDcandesartan cilexetil020838Jun 4, 1998RXNoSEP 13,2005
Export available with Ultimate Plan subscription: 

This preview shows a limited data set. Complete access is available with a Subscription

 

Paragraph IV activity for: ATACAND

Drugname Dosage Strength RLD Submissiondate
candesartan cilexetil and hydrochlorothiazideTablets32 mg/25 mgAtacand HCT3/6/2009
candesartan cilexetil and hydrochlorothiazideTablets16 mg/12.5 mg and 32 mg/12.5 mgAtacand HCT6/25/2008
candesartan cilexetilTablets4 mg, 8 mg, 16 mg and 32 mgAtacand12/22/2006

<- Back to Dashboard


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.


[ Home | Site Tour | Plan Comparison | Free Patent Expiration Newsletter | Patent Inventor Report | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Reddit] [Facebook] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]